Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Drug Delivery Systems. Found 21 abstracts

no pagination
Tomitaka A, Kaushik A, Kevadiya BD, Mukadam I, Gendelman HE, Khalili K, Liu G, Nair M. Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases. Drug discovery today. 2019 Mar;24(3):873-82.
Boushra M, Tous S, Fetih G, Korzekwa K, Lebo DB, Xue HY, Wong HL. Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery. International journal of pharmaceutics. 2016 Sep 10;511(1):462-72.
Boushra M, Tous S, Fetih G, Xue HY, Tran NT, Wong HL. Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin Delivery. Journal of pharmaceutical sciences. 2016 May;105(5):1733-40.
Burns KE, Robinson MK, Thevenin D. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates. Molecular pharmaceutics. 2015 Apr 06;12(4):1250-8.   PMCID: PMC4476257
Rapoport N, Gupta R, Kim YS, O'Neill BE. Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging. J Control Release. 2015 May 28;206:153-60.
Shen C, Chien CR, Geynisman DM, Smieliauskas F, Shih YC. A review of economic impact of targeted oral anticancer medications. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):45-69.
Cukierman E, Khan DR. The benefits and challenges associated with the use of drug delivery systems in cancer therapy. Biochemical pharmacology. 2010 Sep;80(5):762-70.   PMCID: PMC2897922
Jordan VC, Lewis-Wambi JS, Patel RR, Kim H, Ariazi EA. New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis. Breast. 2009 Oct;18 Suppl 3:S10-7.   PMCID: PMC2867601
Astsaturov I, Cohen RB, Harari PM. Clinical application of EGFR inhibitors in head and neck squamous cell cancer. Cancer Treat Res. 2008 Jan;139:135-52.
Held-Warmkessel J. Targeted cancer. These "smart weapons" hit cancer in novel ways. Nursing. 2008 Sep;38(9):26-32.
Langer CJ. Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications. Cancer. 2008 Jun 15;112(12):2635-45.
Mehra R, Cohen RB. New agents in the treatment for malignancies of the salivary and thyroid glands. Hematol Oncol Clin North Am. 2008 Dec;22(6):1279-95, xi.   PMCID: PMC2659655
Jordan VC, Knudson AG. Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen. A personal perspective. Oncology (Williston Park). 2006 May;20(6):553-62; discussion 567-8, 573, 577.
von Mehren M. Imatinib-refractory gastrointestinal stromal tumors: the clinical problem and therapeutic strategies. Current oncology reports. 2006 May;8(3):192-7.
Eisenberg BL. Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors. Oncology (Huntingt). 2003 Nov;17(11):1615-20; discussion 1620, 1623, 1626 passim.
Ma J, Reed KA, Gallo JM. Cells designed to deliver anticancer drugs by apoptosis. Cancer Res. 2002 Mar;62(5):1382-7.
Golemis EA, Ochs MF, Pugacheva EN. Signal transduction driving technology driving signal transduction: factors in the design of targeted therapies. J Cell Biochem Suppl. 2001 Jan;Suppl 37:42-52.
Guo P, Ma J, Li S, Guo Z, Adams AL, Gallo JM. Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model. Cancer Chemother Pharmacol. 2001 Aug;48(2):169-76.
Treat J, Damjanov N, Huang C, Zrada S, Rahman A. Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel. Oncology (Huntingt). 2001 May;15(5 Suppl 7):44-8.
Gallo JM. Pharmacokinetics: model structure and transport systems. In: Amidon GL, Lee PI, Topp EM, editors. Transport processes in pharmaceutical systems. New York: M. Dekker; 2000. p. 55-86.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Drug Delivery Systems

Drug Delivery Systems drug therapy administration & dosage metabolism Female methods Antineoplastic Agents therapeutic use antagonists & inhibitors Human Neoplasms pharmacology drug effects physiology Male Drug Carriers Nanoparticles chemistry Breast Neoplasms Oral Administration Clinical Trials as Topic Tissue Distribution Paclitaxel pharmacokinetics dosage Selective Estrogen Receptor Modulators Neoplasm Drug Resistance Epidermal Growth Factor Receptor Sprague-Dawley Rats Tumor Cell Line Piperazines Caco-2 Cells Monoclonal Antibodies Signal Transduction Combined Modality Therapy Medical Oncology Drug Industry Non-US Gov't Support Pyrimidines Cell Survival Tamoxifen Insulin Rats Squamous Cell Carcinoma Micelles Drug Dose-Response Relationship Head and Neck Neoplasms Animal toxicity Apoptosis US Gov't Support-PHS adverse effects trends Cost-Benefit Analysis Receptor Protein-Tyrosine Kinases peptide Diarrhea HeLa Cells Protein-Tyrosine Kinases Stomatitis Viscosity Oral delivery Hemorrhage Glioma G-Protein-Coupled Receptors nursing Drug Eruptions epidemiology GABA-A Receptors Middle Aged Salivary Gland Neoplasms Cytotoxins Optical Imaging Non-US Gov't Research Support Nanoparticle extravasation pathology mortality stability targeted drug delivery Nude Rats Encapsulation efficiency Phosphatidylcholines Paronychia Protein-Tyrosine Kinase Survivors Nude Mice Drug Interactions Intravital microscopy Protein Databases Pharmaceutical Chemistry etiology Circular Dichroism Patient Education as Topic Endothelial Growth Factors Oligopeptides Treatment Outcome Preclinical Drug Evaluation cytology Phosphoproteins Cultured Cells Estradiol peptides Brain Neoplasms physiopathology Nanodroplets Methylcellulose Triple Negative Breast Neoplasms Polymers Nanoparticle diffusion Solid lipid nanoparticles Pharmaceutical Technology Perfluorocarbon Antineoplastic Antimetabolites Drug Design Gastrointestinal Stromal Tumors Drug delivery Cultured Tumor Cells Phytogenic Antineoplastic Agents Peptide Protein Kinase Inhibitors Liposomes Tryptophan Neoplasm Transplantation oral drug delivery Raloxifene Peptides Drug Discovery radiotherapy Biomedical Research administration & Isoquinolines Adjuvant Chemotherapy economics chemically induced enzymology Microscopy Multiple Drug Resistance Oncologic Nursing Surface Properties Membrane Proteins Propylene glycol Gastrointestinal Neoplasms Phase I Clinical Trials Hypertension Forecasting Vascular Endothelial Growth Factor Receptors Aminobenzoates nanotechnology Cell Membrane Proteome
Last updated on Saturday, July 11, 2020